Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, launches “I Have Cancer,” a social media campaign to raise cancer awareness.
NEW YORK – November 17, 2022 – (Newswire.com)
In keeping with its mission to improve the lives of cancer patients, Massive Bio aims to raise mass awareness about cancer, cancer treatments, and clinical research with “I Have Cancer,” the company’s new social media campaign. “I Have Cancer” will focus on the problems experienced by cancer patients and their loved ones while bringing attention to the importance of cancer prevention. The campaign will also provide up-to-date information about oncology clinical trials for cancer patients interested in pursuing innovative new treatments. Massive Bio, based in New York City, uses a proprietary artificial intelligence platform called SYNERGY-AI to match cancer patients to clinical trials.
“This project is very important for society,” says Erkan Terzi, Global Marketing Vice President for Massive Bio and one of the architects of the “I Have Cancer” campaign. “We have cancer awareness, but the problem is how much we understand cancer and cancer patients. Millions of people die from cancer yearly, and everyone is at risk of getting cancer. With this project, we want to raise cancer awareness, show how we can protect ourselves and our loved ones, and provide information about cancer treatments.”
“Clinical milestones include working with physicians, pharmaceutical and genomic testing providers, and hospitals, as well as our network of oncology clinical trial registration opportunities in Europe and South America,” said Çağatay Çulcuoğlu, co-founder, CFO, and COO of Massive Bio. “We have expanded our patient-engagement activities through advocacy groups, webinars, and the publication of Massive Bio magazine, which informs readers about the latest news in cancer research and clinical trials. Now, with our ‘I Have Cancer’ campaign, we aim to be the voice of patients and their families who need support and are not heard but who want to share their experiences and ideas to build a better tomorrow for future generations.”
The “I Have Cancer” campaign, which will launch in November with posts on Massive Bio’s social media channels, will emphasize the theme that cancer patients are not alone. The importance of cancer foundations and associations will also be highlighted in the campaign, carried out simultaneously on Facebook, Instagram, TikTok, Twitter, LinkedIn, and YouTube. The campaign will use the hashtags #ihavecancer, #cancerawareness, and #massivebio to help cancer patients and their supporters make their voices heard. The campaign will continue until the end of May.
About Massive Bio
Massive Bio’s mission is to provide access to clinical trials for cancer patients worldwide, regardless of where they live or their financial circumstances. Massive Bio solves bottlenecks in recruiting patients for clinical trials with a unique technology-enabled service and big data platform. The company serves pharmaceutical companies, contract research organizations, and hospital networks with a focus on improving the lives of cancer patients and provides oncology-specific data-driven patient recruitment, site selection, and AI-based trial pre-screening services.
Contact Information:
merve sahin
PR Executive
msahin@massivebio.com
+1 844 627 7246
Press Release Service
by
Newswire.com
Original Source:
Massive Bio Launches ‘I Have Cancer’ Campaign
